Science Explorer Interactive view Map

Century Therapeutics (United States)

Research works
61
▲ 172% vs 2013–17
Citations
981
16.1 per fractional work
Top-10% rate
2.9%
record average 16.5%
Open access
39%
world 28%

Not ranked overall: Century Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.79× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 25.27× its world share, 8 worksImmunology and Micro…Neuroscience: 0.16× its world share, 0 worksNeuroscienceComputer Science: 0.27× its world share, 1 worksComputer ScienceEngineering: 0.42× its world share, 2 worksEngineeringMedicine: 2.10× its world share, 13 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 25.3×. Every wedge is a field page.

Which keywords describe research at Century Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Autoimmunity, Genome Engineering, RNA-Guided and Natural Killer Cells.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. Cancer Immunotherapy11▲ 218×2 topics
  2. Immunotherapy10▲ 45×3 topics
  3. CAR T Cells10▲ 420×1 topic
  4. Chimeric Antigen Receptor10▲ 420×1 topic
  5. Autoimmunity3▲ 62×4 topics
  6. Genome Engineering2▲ 117×1 topic
  7. RNA-Guided2▲ 117×1 topic
  8. NK Cell Recognition2▲ 100×1 topic
  9. Natural Killer Cells2▲ 100×1 topic
  10. Glycosylation2▲ 50×2 topics
  11. Genetic Mutations2▲ 12×1 topic
  12. Primary Immunodeficiency2▲ 176×1 topic
  13. Gene Therapy2▲ 27×2 topics
  14. Induced Pluripotent Stem Cells2▲ 192×1 topic
  15. Pluripotent Stem Cells2▲ 97×1 topic
  16. Immunity2▲ 12×3 topics
  17. Inflammation1▲ 2.1×3 topics
  18. Cancer1▲ 2.7×3 topics
  19. Clinical Trials1▲ 5.6×1 topic
  20. Immune Regulation1▲ 33×2 topics
  21. Mammalian Cells1▲ 154×1 topic
  22. Recombinant Protein1▲ 154×1 topic
  23. Stem Cell Regulation1▲ 164×1 topic
  24. Foxp31▲ 108×1 topic
  25. Innate Immunity1▲ 11×2 topics
  26. TGF-ß1▲ 24×1 topic
  27. AAV1▲ 82×1 topic
  28. Assembly Planning1▲ 41×1 topic
  29. Design for Manufacture1▲ 41×1 topic
  30. Viral Vectors1▲ 82×1 topic

Which research topics does Century Therapeutics (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, CRISPR and Genetic Engineering, Immune Cell Function and Interaction and Immunodeficiency and Autoimmune Disorders.

  1. 1 CAR-T cell therapy research Oncology 10 works
  2. 2 CRISPR and Genetic Engineering Molecular Biology 2 works
  3. 3 Immune Cell Function and Interaction Immunology 2 works
  4. 4 Immunodeficiency and Autoimmune Disorders Immunology 2 works
  5. 5 Pluripotent Stem Cells Research Molecular Biology 2 works
  6. 6 Biomedical Ethics and Regulation Physiology 1 works
  7. 7 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
  8. 8 T-cell and B-cell Immunology Immunology 1 works
  9. 9 Virus-based gene therapy research Genetics 1 works
  10. 10 Manufacturing Process and Optimization Industrial and Manufacturing Engineering 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.0%not open61.0%

World: 28% of research is openly available.

with international co-authors7.6%domestic only92.4%

World: 19% is written across borders.

How has Century Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 172% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Philadelphia

All research institutions in Philadelphia

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.